Elizabeth K. Duperret

Author

The Wistar Institute ORCID

Also Known As

E. Duperret, Elizabeth Duperret, Elizabeth K Duperret, Elizabeth K. Duperret

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

The Wistar Institute University of Pennsylvania Inovio Pharmaceuticals (United States)Johns Hopkins University Children's Hospital of Philadelphia

About

Elizabeth K. Duperret is an author at The Wistar Institute specializing in medicine, cell biology, and dermatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	632
2	Cell Biology	5	5	185
3	Immunology	4	4	417
4	Public Health	1	1	133
5	Endocrinology	1	1	133

Elizabeth K. Duperret

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial Kayvon Modjarrad, Christine C. Roberts, Kristin T Mills, The Lancet Infectious Diseases VaccinationVaccine SafetyVaccine DevelopmentImmunologyVirology	2019	314
Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer Filippo Veglia, Vladimir A. Tyurin, Dariush Mohammadyani, Nature Communications	2017	286
Alteration of the Tumor Stroma Using a Consensus DNA Vaccine Targeting Fibroblast Activation Protein (FAP) Synergizes with Antitumor Vaccine Therapy in Mice Elizabeth K. Duperret, Aspen Trautz, Dylan T. Ammons, Clinical Cancer Research	2017	142
In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine Kar Muthumani, Bryan D. Griffin, Sangya Agarwal, npj Vaccines	2016	136
Sex steroids regulate skin pigmentation through nonclassical membrane-bound receptors Christopher A. Natale, Elizabeth K. Duperret, Junqian Zhang, eLife Sex HormonesFemale Reproductive FunctionReproductive BiologyDermatologySkin Pigmentation	2016	133
A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I CD8+ T-cell Responses, Impacting Tumor Challenge Elizabeth K. Duperret, Alfredo Perales‐Puchalt, Regina Stoltz, Cancer Immunology Research	2019	104
<i>CDKN2B</i> Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma Andrew S. McNeal, Kevin Liu, Vihang Nakhate, Cancer Discovery	2015	89
Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor Dan You, Stephen Hillerman, Gregory Locke, Journal for ImmunoTherapy of Cancer	2021	75
Focal-adhesion-independent integrin-αv regulation of FAK and c-Myc is necessary for 3D skin formation and tumor invasion Elizabeth K. Duperret, Ankit Dahal, Todd W. Ridky Journal of Cell Science	2015	57
Synthetic DNA-Encoded Monoclonal Antibody Delivery of Anti–CTLA-4 Antibodies Induces Tumor Shrinkage <i>In Vivo</i> Elizabeth K. Duperret, Aspen Trautz, Regina Stoltz, Cancer Research	2018	51

Page 1